Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Key briefs were filed in litigation on contract pharmacy access laws in Louisiana, Utah and Nebraska.
Category: Contract Pharmacy Protection Bills
Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...] …
Vermont House lawmakers voted Friday to approve an amended contract pharmacy access bill, which includes price caps on some hospitals that has raised concerns from some state health systems.
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...] …
Multiple drugmakers announced exemptions to contract pharmacy restrictions recently, including Vertex, which will automatically exempt states that enact contract pharmacy access laws moving forward.
Four drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in response to a flurry [...] …
Key briefs were filed recently in Nebraska, South Dakota and the 5th Circuit.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Sumitomo Pharma America has announced exemptions to its contract pharmacy restrictions for 340B covered entities in Nebraska, North Dakota, South Dakota and Utah.
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...] …
Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Louisiana.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Merck announced it will exempt South Dakota from its contract pharmacy restrictions and reinstate them in Kansas. Novartis will exempt Missouri from its contract pharmacy restrictions.
Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...] …
Peggy Tighe, a principal at Powers Law, told 340B Report that U.S. Rep. Dusty Johnson’s (R-S.D.) bill "appears to be an attempt to thwart attacks against the 340B program, perhaps to protect GOP state and federal legislators, but it is anti-states' rights and an overreaction to a false and incendiary campaign.”
A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...] …
Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] …
